Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

THERANEXUS SOCIÉTÉ ANONYME

(ALTHX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société THERANEXUS SOCIÉTÉ ANONYME
06/16THERANEXUS  : Minutes of the combined general meeting of 16 june 2021
AN
04/07THERANEXUS  : 2020 full-year results and update on the progress of main programs
PU
04/07THERANEXUS  : 2020 full-year results and update on the progress of main programs
AN
03/10THERANEXUS  : Extends the capacities of neurolead, its asset screening platform,..
AQ
03/09THERANEXUS  : Theranexus extends the capabilities of neurolead, its active agent..
AN
01/22THERANEXUS  : presents an update on the progress of its main programs and announ..
PU
01/19THERANEXUS  : Provides an update on the progress of its main programs and announ..
AQ
01/18THERANEXUS  : Theranexus presents an update on the progress of its main programs..
AN
2020THERANEXUS  : Publishes its 2021 financial agenda
AQ
2020THERANEXUS  : announces its financial calendar for 2021
PU
2020THERANEXUS  : Theranexus announces its financial calendar for 2021
AN
2020THERANEXUS THE  : Lyon neuroscience research center and CERMEP announce the crea..
AQ
2020THERANEXUS  : Lyon Neuroscience Research Center and CERMEP announce the creation..
PU
2020THERANEXUS  : Theranexus, lyon neuroscience research center and cermep announce ..
AN
2020THERANEXUS  : - The Food And Drug Administration issues a favorable opinion on t..
AQ
2020THERANEXUS  : The Food And Drug Administration (FDA) issues a favorable opinion ..
PU
2020THERANEXUS  : The food and drug administration (fda) issues a favorable opinion ..
AN
2020THERANEXUS  : - Presentation of the results of the phase 1b clinical study with ..
AQ
2020THERANEXUS  : Presentation of the results of the phase 1b clinical study of THN2..
PU
2020THERANEXUS  : Presentation of the results of the phase ib clinical study of thn2..
AN
2020THERANEXUS  : TTHERANEXUS and the BBDF Foundation Obtain Orphan Drug Status in E..
AQ
2020THERANEXUS  : and BBDF obtain European "orphan medicinal product" designation fo..
PU
2020THERANEXUS  : publishes its cash position as of September 30, 2020
AQ
2020THERANEXUS  : announces its first half results
AQ
2020THERANEXUS  : takes stock of its scientific news
AQ
2020THERANEXUS  : Theranexus presents its latest scientific news
AN
2020THERANEXUS  : and BBDF Foundation Achieve Orphan Drug and Rare Pediatric Disease..
AQ
2020THERANEXUS  : Theranexus and bbdf obtain orphan drug designation (odd) and rare ..
AN
2020THERANEXUS  : Theranexus to present the results of thn102 for parkinson’s diseas..
AN
2020THERANEXUS  : HALF-YEAR REPORT ON THE LIQUIDITY CONTRACT 1st HALF 2020
AQ
2020THERANEXUS  : Announces its cash position at june 30, 2020 and the establishment..
AQ
2020THERANEXUS  : Theranexus announces its cash position as of 30 june 2020 and impl..
AN
2020THERANEXUS  : obtains non-dilutive financing of EUR 3.4m in the form of a loan g..
AQ
2020THERANEXUS  : Theranexus secures eur 3.4 m loan under the french state guarantee..
AN
2020THERANEXUS  : - 2019 annual results and update on the progress of activities
AQ
2020THERANEXUS  : 2019 full-year results and update on activities
AN
2020THERANEXUS  : Announces Successful Phase 2 Study for THN102 in Parkinson's disea..
AQ
2020THERANEXUS  : Theranexus announces the success of its phase ii trial for thn102 ..
AN
2020THERANEXUS  : publishes its cash position as of December 31, 2019
AQ
2020THERANEXUS  : Theranexus reports cash position as of december 31, 2019
AN
2020THERANEXUS  : Publie son agenda financier 2020
AQ
2020THERANEXUS  : Theranexus announces its financial calendar for 2020
AN
2020THERANEXUS  : Announces the clinical results of its phase ib study demonstrating..
AQ
2020THERANEXUS  : Theranexus announces the clinical results of its phase ib study de..
AN
2019THERANEXUS  : Theranexus and Beyond Batten Disease Foundation (BBDF) announce th..
AN
2019THERANEXUS  : Theranexus reports cash position as of september 30, 2019
AN
2019THERANEXUS  : Theranexus announces its first half 2019 results
AN
2019THERANEXUS  : A new milestone reached for theranexus: inclusion of last patient ..
AN
2019THERANEXUS  : Theranexus announces inclusion of last subject in its phase ib tri..
AN
2019THERANEXUS  : Theranexus announces the publication of two scientific papers and ..
AN
2019THERANEXUS  : Theranexus raises approximately 2.2 million euros in a placement r..
AN
2019THERANEXUS  : Theranexus announces the launch of a capital increase by private p..
AN
2019THERANEXUS  : Theranexus reports cash position as of june 30, 2019
AN
2019THERANEXUS  : Theranexus and Beyond Batten Disease Foundation (BBDF) announce ag..
AN
2019THERANEXUS  : THERANEXUS INVITED TO JOIN IN THE HEALTHTECH INVESTOR DAYS (HTID) ..
AN
2019THERANEXUS  : Theranexus announces the formation of its scientific board
AN
2019THERANEXUS  : Theranexus to present new data on neuron-glia interactions at two ..
AN
2019THERANEXUS  : Theranexus announces issuance of chinese patent covering its drug ..
AN
2019THERANEXUS  : Theranexus provides 2018 full-year results and update on activitie..
AN
2019THERANEXUS  : Theranexus announces research collaboration with irisa* using arti..
AN
2019THERANEXUS  : Theranexus to present new scientific data on drug candidate thn201..
AN
2019THERANEXUS  : Theranexus announces preliminary results of phase ii trial of thn1..
AN
2019THERANEXUS  : Theranexus reports cash position as of 31 december 2018 and provid..
AN
2019THERANEXUS  : THERANEXUS set to receive EUR 6.2 million in funding from the Fren..
AN
2019THERANEXUS  : Theranexus announces its financial calendar for 2019
AN
2018THERANEXUS  : Theranexus announces appointment of jerome martinez to its board o..
AN
2018THERANEXUS  : Theranexus september 30th cash position and business update
AN
2018THERANEXUS  : Theranexus announces inclusion of last patient in phase ii trial o..
AN
2018THERANEXUS  : Theranexus plans to expand its phase ii pipeline with a third prog..
AN
2018THERANEXUS  : Theranexus announces that rodolphe besserve will join its board of..
AN
2018THERANEXUS  : Theranexus announces a new european patent protecting thn201, its ..
AN
2018THERANEXUS  : Recognition of the scientific excellence of theranexus
AN
2018THERANEXUS  : THERANEXUS ANNOUNCES ITS FIRST HALF 2018 RESULTS - CASH POSITION A..
AN
2018THERANEXUS  : THERANEXUS OBTAINS THE AUTHORIZATION TO START A PHASE Ib CLINICAL ..
AN
2018THERANEXUS  : Theranexus announces the inclusion of the first patient in its pha..
AN
1  2Next